ACTIDOSE activated charcoal 208 mg/mL Suspension, 120 mL
by Padagis US LLC · 120 mL in 1 BOTTLE (0574-0520-04)
NDC 00574-0520-04
🏷️ FDA NDC (as labeled)
0574-0520-04
billing pads the labeler segment with a zero
This package
Contains120 mL
Pack sizes4 compare ↓
OTC
On market
Non-controlled
🗂️ Data synced Aug 13, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
0574-0520-04
Product NDC
0574-0520
11-digit billing NDC
00574052004
NCPDP billing unit
ML — per mL (volume)
UNII
2P3VWU3H10
Application #
M023
SPL Set ID
76e4fe6a-afd4-4f68-b12d-0b094f750615
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2020-12-05
Route
ORAL
Dosage form
SUSPENSION
Substance
ACTIVATED CHARCOAL
GCN Seq No
057761
GCN
22989
HICL code
001116
Ingredient (HICL)
Activated Charcoal/Sorbitol
HIC1 code
C
Therapeutic class — broad (HIC1)
Electrolyte Balance/Metabolism/Nutrition
HIC2 code
C8
Therapeutic class — intermediate (HIC2)
Antidotes To Poisons
HIC3 code
C8E
Therapeutic class — specific (HIC3)
Antidotes,Miscellaneous
AHFS code
56:04.00.00
AHFS class
Antacids And Adsorbents
FDB label name
ACTIDOSE 25 GM LIQUID
FDB brand name
Actidose
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 0574-0520-04 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00574-0520-04. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Charcoal preparations class.
Drug family (ATC)
Charcoal preparations
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerPadagis US LLC
FDA applicationM023 (OTC MONOGRAPH DRUG)
Labeler code00574
First marketedDec 2020
Product typeHuman Otc Drug
Portfolio63 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name ACTIDOSE 25 GM LIQUID Ingredient Activated Charcoal/Sorbitol
🧪 What is this product?
Actidose is an oral suspension containing activated charcoal, marketed as an over-the-counter monograph drug. Activated charcoal is typically used in emergency and poison control settings to bind certain ingested substances in the stomach and gastrointestinal tract, potentially reducing their absorption into the bloodstream. This product comes as a liquid suspension for swallowing and is commonly found in first-aid kits and medical facilities.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about activated charcoal?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII XF417D3PSL
Anhydrous citric acid is a sour, crystalline powder derived from citric acid with water removed. In medicines, it acts as a buffer to control pH, adds tartness to improve taste, and helps tablets disintegrate.
-
UNII PDC6A3C0OX
Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
-
UNII 6DC9Q167V3
Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
-
UNII 506T60A25R
Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
5 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesCitric acid, glycerin, propylene glycol, sorbitol, and water.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Actidose 208 mg/mLthis 00574-0520-04 | Padagis | 120 ml | — | — | FDA listed | — |
| Actidose Aqua 208 mg/mL 00574-0521-04 | Padagis | 120 ml | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2020
On the market since
Dec 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for ACTIDOSE (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 36%
Female · 63%
Unknown · 1%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 00574-0520-04 You're viewing this | 120 mL in 1 BOTTLE (0574-0520-04) | 2020-12-05 | Active |
| 00574-0520-08 | 240 mL in 1 BOTTLE (0574-0520-08) | 2021-02-10 | Active |
| 00574-0520-74 | 120 mL in 1 TUBE (0574-0520-74) | 2021-02-19 | Active |
| 00574-0520-76 | 240 mL in 1 TUBE (0574-0520-76) | 2020-12-05 | Active |
Pack size FAQ
What quantity is in NDC 00574-0520-04?
NDC 00574-0520-04 contains 120 mL — 120 ml in 1 bottle.
What is the difference between NDC 00574-0520-04 and NDC 00574-0520-74?
Both are ACTIDOSE activated charcoal 208 mg/mL Suspension — the drug itself is identical. NDC 00574-0520-04 is the 120 mL package, while NDC 00574-0520-74 is the 120 ml package.
What NDC number is used to bill for this package of ACTIDOSE activated charcoal 208 mg/mL Suspension?
Bill NDC 00574-0520-04 — the 11-digit billing format is 00574052004. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 0574-0520-04, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 00574-0520-04, written without dashes as 00574052004. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 00574-0520-04, the first segment (00574) is the labeler code FDA assigned to Padagis US LLC; the middle segment (0520) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (04) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Padagis US LLC. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 120 ml (00574-0520-74), 240 ml (00574-0520-08), 240 ml (00574-0520-76). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Padagis US LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses • For emergency use to adsorb swallowed poisons.
⏱️ Dosage and Administration ▾
Directions Oral dosage: 20 to 30 grams of activated charcoal in a minimum of 8 ounces of liquid or as directed by a health professional. Repeat dose immediately, if possible. 1.
Shake well. 2. Snip tapered tip as indicated in drawing and remove.
Holding the tube upright, carefully cut off tube closure. Reattach tapered tip and connect to any charcoal administration set or squeeze contents in a cup with a minimum of 4 ounces of liquid for patient to drink. 3.
If previous attempts to contact a poison control center, emergency medical facility, or health professional were unsuccessful, continue trying. 4. Keep patient active and moving.
5. Save the container of poison.
⚠️ Warnings ▾
Warnings • Do not give activated charcoal until after the patient has vomited unless directed by a health professional. • Do not use in persons who are not fully conscious. • Do not use this product, unless directed by a health professional, if turpentine, corrosives (such as alkalies (lye) and strong acids), or petroleum distillates (such as kerosene, gasoline, paint thinner, cleaning fluid or furniture polish), have been ingested.
📦 Storage and Handling ▾
Other information • Store at 20-25°C (68-77°F) [see USP Controlled Room Temperature]. Do not refrigerate.
🧪 Active Ingredient ▾
Active ingredient (in each tube) Activated Charcoal
🧪 Inactive Ingredients ▾
Inactive Ingredients Citric acid, glycerin, propylene glycol, sorbitol, and water.
🎯 Purpose ▾
Purpose Poison Adsorbent
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.